Enliven Therapeutics
ELVN
#5204
Rank
$1.54 B
Marketcap
$26.00
Share price
11.83%
Change (1 day)
19.60%
Change (1 year)

Enliven Therapeutics (ELVN) - Total debt

Total debt on the balance sheet as of September 2025 : $0.38 Million USD

According to Enliven Therapeutics's latest financial reports the company's total debt is $0.38 Million USD. A companyโ€™s total debt is the sum of all current and non-current debts.

Enliven Therapeutics - Total debt on balance sheet (from 2021 to 2025)

Total debt by year

Year Total debt Change
2024-12-31N/A-100%
2023-12-31$0.33 M3.72%
2022-12-31$0.32 M103.14%
2021-12-31$0.15 M51.43%
2020-12-31$0.1 M